Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Completed 6Terminated 2Unknown 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Endometrial Neoplasms 3Anorexia 3Weight Loss 2Cachexia 2Body Weight 2Squamous Intraepithelial Lesions 1Recurrence 1Pancreatic Neoplasms 1Neoplasms 1Lung Neoplasms 1Breast Neoplasms 1Body Weight Changes 1

Interventions

Megestrol Acetate 2Blood Specimen Collection 2anamorelin 1Melatonin 1Ibuprofen 1Fundoplication 1Food 1Flurandrenolone 1Exercise 1Dietary Supplements 1Deuterium Oxide 1Deuterium 1Cyproheptadine 1Clarithromycin 1Cholecystectomy 1Caseins 1Body Height 1Atenolol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Cachexia × Megestrol Acetate × Clear all
NCT00637728 2016-06-23

Treatment of Cancer-anorexia Using Megestrol Acetate Concentrated Suspension in Lung or Pancreatic Cancer Patients

Par Pharmaceutical, Inc.

Phase 3 Terminated
5 enrolled 8 charts
GastrointestinalThoracic

Anorexia, Body Weight, Cachexia, Lung Neoplasms, Pancreatic Neoplasms, Weight Loss

NCT00637806 2016-05-02

Treatment of Cancer-associated Anorexia Using Megestrol Acetate Concentrated Suspension

Par Pharmaceutical, Inc.

Phase 3 Terminated
4 enrolled 6 charts

Anorexia, Body Weight, Cachexia, Neoplasms, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡